News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
130 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Bay Area’s Adamas Pharma Pays Big Bucks to Double HQ
With the commercial launch of newly-approved Parkinson’s disease treatment Gocovri, Bay Area drugmaker Adamas is growing.
January 22, 2018
·
2 min read
·
Alex Keown
Centinel Spine Snags $132M Funding Round
The company just closed its acquisition of J&J subsidiary DePuy Synthes’ Prodisc assets last week.
January 22, 2018
·
1 min read
Business
FDA Furloughs 42% of Staff in Government Shutdown
The layoff leaves 58 percent of FDA employees on the job, which Gottlieb said is higher than the previous shutdown in 2013.
January 22, 2018
·
3 min read
·
Alex Keown
Deals
Post-Actelion Takeout, 2 Reasons Why J&J Could Go Back Into M&A Mode
Most investors and analysts are expecting 2018 to be a big year for mergers and acquisitions.
January 22, 2018
·
2 min read
·
Mark Terry
Deals
Sanofi CEO Finally Scores With $11.6B Buyout of Biogen’s Spinoff Bioverativ
The deal has Sanofi paying $105 per share in cash.
January 22, 2018
·
3 min read
·
Mark Terry
BioCapital
3 Diabetes Biotechs That Could Surge 50% or More in 2018
Wall Street projects these three biotechs will grow the fastest over the next 12 months.
January 22, 2018
·
1 min read
Policy
New Details Emerge on the Murder of Apotex Founder and Wife
Private investigators believe the prominent billionaire couple were murdered by multiple people two days before their bodies were discovered.
January 22, 2018
·
1 min read
Business
Imaging3 Announces Addition of Dr. Douglas Beall to the Scientific Advisory Board
Dr. Beall brings both radiology and pain management experience to the SAB.
January 22, 2018
·
4 min read
Deals
Week in Review: Sinocare Eyes $4B Deal for J&J Diabetes Device Business
Sinocare of Changsha may bid as much as $4B to acquire J&J’s diabetes medical device subsidiaries
January 22, 2018
·
1 min read
Drug Development
Amgen Jumps as Migraine Drug Wows in Late-Stage Study
In the study, 246 patients were randomized to receive Aimovig or placebo over a 12-week treatment phase.
January 22, 2018
·
2 min read
·
Alex Keown
1 of 13
Next